Seminar Schedule
2009 - 2010 Sep 16: John Denu, PhD, Department of Biomolecular Chemistry, University of Wisconsin - Medison
10:30 AM, in 2-520 Moos Tower
Topic: Biology and Chemistry of Reversible Protein Acetylation Oct 21: Katherine Seley-Radtke, PhD, Department of Chemistry and Biochemistry, University of Maryland
10:30 AM, in 3-125 Mayo Bldg
Topic: Exploring Structural Diversity in Drug Design (Rescheduled to Mar 17, 2010) Nov 11: Joseph Metzger, PhD, Department of Integrative Biology and Physiology, University of Minnesota
10:30 AM, in 3-125 Mayo Bldg
Topic: Gene Delivery of a pH Sensitive Molecular Switch Molecule in the Heart Nov 16: Michael Farzan, PhD, Department of Microbiology and Molecular Genetics, Harvard Medical School
10:30 AM, in TBA
Topic: TBA (Cancelled) Dec 16: Timothy Palzkill, PhD, Department of Molecular Virology and Microbiology, Baylor College Medicine
10:30 AM, in TBA
Topic: TBA Jan 20: Rodney Johnson, PhD, Department of Medicinal Chemistry, University of Minnesota
10:30 AM, in TBA
Topic: TBA Feb 3: Michael Jung, PhD, Department of Chemistry and Biochemistry, University of California - Los Angeles
10:30 AM, in TBA
Topic: TBA Feb 17: Dennis Hruby, PhD, Sigma Tech
10:30 AM, in TBA
Topic: TBA Mar 17: Katherine Seley-Radtke, PhD, Department of Chemistry and Biochemistry, University of Maryland
10:30 AM, in TBAg
Topic: Exploring Structural Diversity in Drug Design Apr 21: Guy Carter, PhD, Chemical Technologies in Chemical and Screening Sciences
10:30 AM, in TBA
Topic: TBA May 19: George Wilcox, PhD, Department of Neuroscience, University of Minnesota
10:30 AM, in TBA
Topic: TBA Jun 16: Scott Franzblau, PhD, Department of Medicinal Chemistry and Pharmacognosy, University of Illinois - Chicago
10:30 AM, in TBA
Topic: TBA 2008 - 2009 Sep 17: Bradley Smith, PhD, Department of Chemistry and Biochemistry, University of Notre Dame
10:30 AM, in 2-620 Moos Tower
Topic: The Promise and Practice of Molecular Imaging in Drug Discovery. Oct 15: Pradipsinh Rathod, PhD, Department of Chemistry, University of Washington
10:30 AM, in 1-451 Moos Tower
Topic: New Antimetabolites Against Malaria. Nov 19: David Newman, DPhil, Natural Products Branch, National Cancer Institute
10:30 AM, in 1-451 Moos Tower
Topic: Wanderings with Nature: Mother Nature and Natural Product. Dec 17: Michael Staake, PhD, Center for Drug Design, University of Minnesota
10:30 AM, in 5-125 Moos Tower
Topic: Phosphonoxins: Novel Phosphonate Analogs of Antifungal Polyxins. Jan 21: Kevin Reynolds, PhD, Department of Chemistry, Portland State University
10:30 AM, in 2-520 Moos Tower
Topic: It ALL Starts with abH-Fatty Acid and Prodiginie Biosynthesis. Feb 18: Yinduo Ji, PhD, Department of Veterinary and Biomedical Sciences, University of Minnesota
10:30 AM, in 2-520 Moos Tower
Topic: Regulated Antisense RNA in Anti-Infective Drug Discovery. Mar 18: Michael Jung, PhD, Department of Chemistry and Biochemistry, UCLA
10:30 AM, in 2-520 Moos Tower (Canceled)
Topic: Rational Drug Design for the Treatment of Hormone Refractory Prostate Cancer. Apr 15: Ingo Muegge, PhD, Boehringer Ingelheim Parmaceuticals, Ridgefield, CT
10:30 AM, in 2-520 Moos Tower
Topic: De Novo Design of Drug-Like Molecules. May 20: Yves Pommier, MD PhD, Laboratory of Molecular Pharmacology, National Cancer Institute
10:30 AM, in 2-520 Moos Tower
Topic: HIV Integrase Inhibitors. Jun 17: Matthew Brenner, MD, Department of Medicine - Pulmonary and Critical Care, University of California - Irvine
10:30 AM, in 2-690 Moos Tower
Topic: Diffuse Optical Spectroscopy Assessment of Cyanide Poisoning and Treatment in an Animal Mode. Jul 13: Frank Seela, PhD, Institute of Chemistry, University of Osnabruck, Germany
10:30 AM, in 5-125 Moos Tower
Topic: 1,2,3-Triazoles and 1,2.3-Triazines as Building Blocks for Modification and Conjugation of Nucleosides and Oligonucleotides. 2007 - 2008 Sep 19: Vern L. Schramm, PhD, Department of Biochemistry, Albert Einstein College of Medicine, Yeshiva University
10:30 AM, in 2-530 Moos Tower
Topic: Enzymatic Transition States and Inhibitor Design. Oct 17: Carole Bewley, PhD, Laboratory of Bioorganic Chemistry, NIH
10:45 AM, in 2-530 Moos Tower
Topic: Structural studies of HIV-1 coreceptors and inhibitors. Nov 14: Gerry Boss, MD, Department of Medicine, UCSD
10:30 AM, in 2-530 Moos Tower
Topic: Of Fire, Bugs, and Terrorists: The Many Faces of Cyanide. Dec 19: Chengguo Xing, PhD, Department of Medicinal Chemistry, University of Minnesota
10:30 AM, in 1-450 Moos Tower
Topic: Studies of HA 14-1 - Can we selectively target ER-specific Bcl-2 protein? Mar 19: Suzanne Walker, PhD, Department of Chemistry and Biochemistry, Harvard
10:30 AM, in 5-125 Moos Tower
Topic: Glycosyltransferase Inhibitros. Apr 16: Mark Walter, PhD, Department of Microbiology and Structural Biology, University of Alabama
10:30 AM, in 2-650 Moos Tower
Topic: Structural Analysis of Cytokine Receptor Interactions to Aid Drug Discovery. May 7: Nikunj Somia, PhD, Department of Genetics, Cell Biology and Development, University of Minnesota
10:30 AM, in 2-580 Moos Tower
Topic: Gene Discovery Using Retroviral Vectors: From Cancer to HIV. May 21: Matthew Brenner, MD, Department of Medicine - Pulmonary and Critical Care, University of California - Irvine
10:30 AM, (Canceled)
Topic: Diffuse Optical Spectroscopy Assessment of Cyanide Poisoning and Treatment in an Animal Mode. 2004 - 2005 Nov. 15: Dr. Dan Cook, Carlsbad Pharmaceuticals
11:00 AM in 7-193/195 WDH
Topic: Novel Anti-HIV Agents: Nucleoside Triphosphate Mimics (N3PMs) and their Prodrugs (N3PM-PDs). Nov. 30: Prof. Peter Tonge, SUNY-Stonybrook
10:15 AM in 7-193/195 WDH
Topic: Mycolic acids, Menaquinone and Mycobactin: Tuberculosis Drug Discovery Beyond the Magic Mountain. Jan 10: Dr. Leo Beigelman, Transgenomic, Inc
9:15 AM in 7-193/195 WDH
Topic: Medicinal Chemistry of RNA-based Therapeutics. Feb 21: Lizbeth Hedstrom, PhD, Brandeis University
10:30 AM in 2-580 Moos Tower
Topic: IMP Dehydrogenase and the Dynamics of Drug Selectivity. May 4: Robert K. Roth, MS JD, Miller Canfield PL
1:30 PM in 7-193/195 WDH
Topic: Protecting Your Interests: Patent Law and Research. Jul 19: Shiv Kumar, PhD, G.E. Healthcare/Amersham Biosciences
10:30 AM in 7-193/195 WDH
Topic: Nucleotide Chemistry & Biotechnology Applications.
|
